Allogene Therapeutics, Inc. - ALLO
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Aug 25, 2026 | SVP, General Counsel | S | D | 29,697.0 | 2.12 | 62,957.64 | 488,267.0 | View | |
| Jul 06, 2026 | President and CEO | A | A | 476,190.0 | 0.0 | 0.0 | 476,190.0 | View | |
| Jul 06, 2026 | President and CEO | A | A | 134,530.0 | 0.0 | 0.0 | 134,530.0 | View | |
| Jun 23, 2026 | — | A | A | 95,400.0 | 0.0 | 0.0 | 95,400.0 | View | |
| Jun 23, 2026 | — | A | A | 144,400.0 | 0.0 | 0.0 | 144,400.0 | View | |
| Jun 23, 2026 | — | A | A | 95,400.0 | 0.0 | 0.0 | 95,400.0 | View | |
| Jun 23, 2026 | — | A | A | 95,400.0 | 0.0 | 0.0 | 95,400.0 | View | |
| Jun 23, 2026 | — | A | A | 95,400.0 | 0.0 | 0.0 | 95,400.0 | View | |
| Jun 23, 2026 | — | A | A | 95,400.0 | 0.0 | 0.0 | 95,400.0 | View | |
| Jun 23, 2026 | — | A | A | 95,400.0 | 0.0 | 0.0 | 95,400.0 | View | |
| Jun 23, 2026 | — | M | D | 47,700.0 | 0.0 | 0.0 | 0.0 | View | |
| Jun 23, 2026 | — | M | A | 47,700.0 | 0.0 | 0.0 | 398,463.0 | View | |
| Apr 23, 2026 | SVP, Finance | S | D | 9,586.0 | 2.31 | 22,143.66 | 124,517.0 | View | |
| Apr 02, 2026 | SVP, Chief Technical Officer | S | D | 2,867.0 | 2.5 | 7,167.5 | 195,338.0 | View |